scholarly journals A novel mutation in SLC37A4 gene in a Sri Lankan boy with glycogen storage disease type Ib associated with very early onset neutropenia

Author(s):  
Vajira HW Dissanayake ◽  
Jayan D Jayasinghe ◽  
Viranga Tilakaratna
2018 ◽  
Vol 31 (3) ◽  
pp. 331-338 ◽  
Author(s):  
Chunyun Li ◽  
Lihua Huang ◽  
Lang Tian ◽  
Jia Chen ◽  
Shentang Li ◽  
...  

AbstractBackground:PHKG2gene mutation can lead to liver phosphorylase kinase (PhK) deficiency, which is related to glycogen storage disease type IX (GSD IX). GSD IXc due toPHKG2mutation is the second most common GSD IX.Methods:We identified a novel mutation (c.553C>T, p.Arg185X) inPHKG2in a Chinese family and verified it by next-generation and Sanger sequencing. The mutation spectrum of thePHKG2gene was summarized based on 25 GSD IXc patients withPHKG2mutations.Results:We found that missense mutation (39%) was the most common type of mutation, followed by nonsense mutation (23%). Mutations were more prevalent in Asian (12/25) and European (9/25) populations than in populations from elsewhere. The exons had more sites of mutation than the introns, and exons 3 and 6 were the most frequent sites of mutations.Conclusions:This study expands our knowledge of thePHKG2gene mutation spectrum, providing a molecular basis for GSD IXc.


1998 ◽  
Vol 11 (S1) ◽  
pp. S323-S324 ◽  
Author(s):  
Pascale Trioche ◽  
Philippe Labrune ◽  
Michel Odièvre ◽  
Michelle Hedchouel ◽  
Jean-François Deleuze

2018 ◽  
Vol 21 (2) ◽  
pp. 55-57
Author(s):  
S Dorum ◽  
O Gorukmez

Abstract Glycogen storage disease type Ia (GSD1A) is caused by mutations in the G6PC gene. The G6PC gene was first cloned in 1993. Since then, many different mutations have been identified leading to this disease. Hepatomegaly is one of the important clinical manifestations of the disease. A 23-day-old girl was admitted to the hospital due to respiratory distress. Her physical examination was normal except for tachypnea. She had hypoglycemia, lactic academia, hyperlipidemia and hyperuricemia. With these clinical findings, GSD1A was considered in the patient and the diagnosis was genetically confirmed. By direct sequencing of the G6PC gene, we identified a novel homozygous variation (c.137T>G/p.Leu46Arg) in the patient and the healthy mother and father were heterozygotes for the variant. Here we present a case with a novel homozygous missense mutation c.137T>G/p.Leu46Arg in the G6PC gene leading to GSD1A clinical findings except early hepatomegaly. These findings expand the spectrum of causative mutations, and clinical findings in GSD1A.


2010 ◽  
Vol 11 (1) ◽  
Author(s):  
Ana Priscila Soggia ◽  
Maria Lúcia Correa-Giannella ◽  
Maria Angela Henriques Fortes ◽  
Ana Mercedes Cavaleiro Luna ◽  
Maria Adelaide Albergaria Pereira

2016 ◽  
Vol 2016 ◽  
pp. 1-5 ◽  
Author(s):  
Anca Zimmermann ◽  
Heidi Rossmann ◽  
Simona Bucerzan ◽  
Paula Grigorescu-Sido

Background. Glycogen storage disease type III (GSDIII) is a rare metabolic disorder with autosomal recessive inheritance, caused by deficiency of the glycogen debranching enzyme. There is a high phenotypic variability due to different mutations in theAGLgene.Methods and Results. We describe a 2.3-year-old boy from a nonconsanguineous Romanian family, who presented with severe hepatomegaly with fibrosis, mild muscle weakness, cardiomyopathy, ketotic fasting hypoglycemia, increased transaminases, creatine phosphokinase, and combined hyperlipoproteinemia. GSD type IIIa was suspected. Accordingly, genomic DNA of the index patient was analyzed by next generation sequencing of the AGL gene. For confirmation of the two mutations found, genetic analysis of the parents and grandparents was also performed. The patient was compound heterozygous for the novel mutation c.3235C>T, p.Gln1079⁎(exon 24) and the known mutation c.1589C>G, p.Ser530⁎(exon 12). c.3235 >T, p.Gln1079⁎was inherited from the father, who inherited it from his mother. c.1589C>G, p.Ser530⁎was inherited from the mother, who inherited it from her father.Conclusion. We report the first genetically confirmed case of a Romanian patient with GSDIIIa. We detected a compound heterozygous genotype with a novel mutation, in the context of a severe hepatopathy and an early onset of cardiomyopathy.


Sign in / Sign up

Export Citation Format

Share Document